More News
A sweeping national study with “enormous” public health implications has shown that controlling blood pressure more intensively can slow the debilitating progression of kidney disease in many African-American patients.
Read about NIH's African-American Study of Kidney Disease and Hypertension »
The Miller School’s Jianqin Wei, M.D., has been named the 2010 “Stop Heart Disease Researcher of the Year” by the Florida Heart Research Institute. Dr. Wei, a trained interventional cardiologist, unrelenting researcher and newly appointed assistant research professor of medicine, was honored on August 21 at the annual meeting of the Florida Chapter of the American College of Cardiology held in Kissimmee.
Read more about Dr. Wei »
Jean L. Wright, M.D., assistant professor of radiation oncology and member of the Sylvester Comprehensive Cancer Center, has been recognized as an Educator of the Year by the Association of Residents in Radiation Oncology (ARRO). The award, given to 40 educators across the nation, is presented in partnership with the American Society for Radiation Oncology (ASTRO).
Read more about Dr. Wright »
The team behind the Smoke Free Campus Initiative wants you to get involved. On March 1, the Miller School campus went smoke free, taking a bold step toward a healthier lifestyle and improving the medical campus for all. Signs are up across campus and smoking cessation classes are in full swing, but we still need help spreading the word.
Read more about this Thursday's Smoke Free Ambassadors' Lunch-and-Learn »
In what’s being called the start of a new era in treating hepatitis C, a team that includes a leading Miller School physician has discovered a drug that appears to dramatically increase the success of standard therapy. For decades, patients with hepatitis C have faced an unpleasant reality: the standard therapy is effective in only 40 percent of cases and the side effects of the lengthy regimen can be debilitating.
Read more about the advancement »
News & Events »
